Clinical Trials Browser

Phase 1 × INDUSTRY × tusamitamab ravtansine × Clear all

NCT03324113 2025-08-05

Evaluation of SAR408701 in Japanese Patients With Advanced Malignant Solid Tumors

Phase 1 Completed

Neoplasms

NCT05429762 2025-04-06

TusaRav-QT

Phase 1 Terminated

Neoplasms

NCT02187848 2025-02-10

Evaluation of SAR408701 in Patients With Advanced Solid Tumors

Phase 1 Terminated

Neoplasms